Article ID Journal Published Year Pages File Type
6183061 Gynecologic Oncology 2012 8 Pages PDF
Abstract
► 17β-estradiol increases invasion and proliferation of ovarian cancer in vitro. ► The effects of 17β-estradiol are reversed by a 3rd generation SERM, bazedoxifene. ► Neither 17β-estradiol nor bazedoxifene changes tumor burden in genetic mouse model.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis
Authors
, , , , , , , , , , ,